Back to Clinical Trials

Clinical Trials: General Internal Medicine


Source: University of British Columbia
Miscommunication during patient handover can jeopardize patient safety and is the focus of Quality Improvement initiatives by many organizations. It is widely recognized that such miscommunication is preventable using a number of strategies identified in the literature. Currently, there is no formal handover process of General Internal Medicine in-patients, otherwise known as the Clinical Teaching Unit (CTU) at Vancouver General Hospital, which is a major ... Read More
Last Updated: 13 Jan 2016
Source: University of Athens
To develop a score that can predict early from diagnosis of Clostridium difficile infection (CDI) the risk for relapse and of unfavorable outcome. This score can be used in the future to identify patients will benefit from fidaxomicin treatment. Read More
Last Updated: 30 Oct 2016
Source: Hellenic Cooperative Oncology Group
The purpose of this study is to explore the efficacy and safety of everolimus administered as a first-line treatment in newly-diagnosed patients with advanced or inoperable Gastrointestinal (GI) or pancreatic neuroendocrine tumors. Read More
Last Updated: 28 Aug 2016
Source: Positive Trial Group
The study is being conducted to compare the effect of standard treatment (target LDL-C level: <120 mg/dL (JASGL 2007 target level)) and intensive treatment (target LDL-C level: <70 mg/dL) in the prevention of major adverse cardiac events (MACE) in hypercholesterolemia patients with concomitant type 2 diabetes and hypertension. Read More
Last Updated: 29 May 2011
Source: Unidad de Cirugía Cardiovascular
A national cross-sectional survey was conducted to evaluate recommendations on clinical preventive services and additional information on non-communicable disease prevention. Trained surveyors interviewed interns, residents and attendings of the Internal Medicine departments of all teaching hospitals in Guatemala. Analysis compared recommendation practices within and between hospitals. Read More
Last Updated: 17 Jan 2012
Source: Abbott
Post marketing surveillance of safety and efficacy for Cholib in Korean patients under the "New Drug Re-examination" Read More
Last Updated: 01 Dec 2016
Source: Rambam Health Care Campus
Several studies have shown the importance of Telephone follow-up in reducing hospital readmissions for heart failure. Therefore, we aimed in this cohort to investigate whether telephone follow-up with patients discharged from the general internal department improves patients' satisfaction, increases compliance to treatment and reduces adverse effects. Patients are recruited from the department of general internal medicine who gave informed consent and could ... Read More
Last Updated: 09 Apr 2007
Source: Yonsei University
As increasing tidal volume, the cross sectional area and circumference of Internal Jugular Vein (IJV) could increase. And In the previous study, Trendelenburg position can increase size of IJV. So investigators would compare the cross sectional area, circumference of IJV and peak airway pressure in neutral and Trendelenburg position Read More
Last Updated: 17 Apr 2011
Source: University of Ulm
This trial is a study on all-trans retinoic acid in combination with induction and consolidation therapy as well as pegfilgrastim after consolidation therapy in younger patients with newly diagnosed acute myeloid leukemia (AML). Read More
Last Updated: 21 Jul 2014
Source: Hellenic Cooperative Oncology Group
The purpose of this study is to determine whether gemcitabine and pazopanib are effective in the treatment of inoperable, locally advanced or metastatic biliary tree cancer (cholangiocarcinoma or gallbladder carcinoma). Read More
Last Updated: 09 Feb 2016
Source: EMD Serono
The purpose of this study is to learn whether atacicept treatment leads to improvement in kidney function in subjects with active lupus nephritis in combination with mycophenolate mofetil (MMF) and corticosteroids. The study was sponsored by Merck Serono International; operational oversight was provided by ZymoGenetics. Read More
Last Updated: 21 Feb 2016
Source: Panion & BF Biotech Inc.
The purpose of the study is to determine the effect and optimum dose and evaluate the safety of ferric citrate, administered three times daily (TID) immediately after meals for a total daily dose of 4 or 6 grams for 56 days, on serum phosphate (PO4) levels in subjects with end stage renal disease (ESRD). Read More
Last Updated: 22 Dec 2013
Source: University of Ulm
This is a study looking at all-trans retinoic acid in combination with standard induction and consolidation therapy in older patients with newly diagnosed acute myeloid leukemia (AML). Read More
Last Updated: 11 Oct 2011
Source: AstraZeneca
This study aims to evaluate the asthma control status, asthma symptoms (severity, frequency, and limitations on activities, etc.), QOL, and use of drugs for asthma attack in adult asthma patients. Read More
Last Updated: 13 Jul 2016
Source: Listen Trial Group
The purpose of this study is to compare the effect of rosuvastatin and atorvastatin on lipid lowering effect and glucose metabolism in hypercholesterolemia patients with diabetes mellitus. Read More
Last Updated: 03 Mar 2015
Source: Hellenic Cooperative Oncology Group
The purpose of this study is to evaluate the efficacy and safety of the combination of Cisplatin,5-Fluorouracil(5FU) and Afatinib as first-line therapy in patients with advanced gastric or gastroesophageal junction cancer. The study will include 55 patients in all. The patients will receive open-label Cisplatin intravenous 75mg/m2 on Day 1, 5FU 750mg/m2 at 24-hour intravenous infusion on Days 1-4, and Afatinib 40mg per os on Days 3-5, 8-12, 15-19. The ... Read More
Last Updated: 29 Sep 2016
Source: Hellenic Cooperative Oncology Group
The purpose of this study is to determine whether cabazitaxel is effective in the treatment of metastatic breast cancer. Read More
Last Updated: 05 Oct 2016
Source: Shire
The purpose of this study is to proof increasing patient satisfaction and preservation of quality of life in patients with Morbus Fabry disease receiving their Enzyme Replacement Therapy with Replagal (Agalsidase alfa) at home compared to receiving the infusions at the clinic or at doctor's practice. Read More
Last Updated: 08 May 2016
Source: University of Pennsylvania
In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot tested, and then implemented and tested in nine primary care and OB/GYN practices within the University of Pennsylvania Health System. Read More
Last Updated: 17 Aug 2016
Source: Hellenic Cooperative Oncology Group
This phase II open-label study will be performed to evaluate the response rate of brain metastases from lung and breast tumors under treatment with WBRT and lapatinib. Read More
Last Updated: 29 Dec 2014
Page 1 of 50